正商實業(00185.HK)斥6135.4萬元收購新鄉市一幅地塊
格隆匯9月17日丨正商實業(00185.HK)發佈公告,於2020年9月17日,公司間接全資附屬公司河南正商新古置業有限公司以代價人民幣6135.4萬元成功於新鄉縣自然資源局提呈出售所舉辦的國有建設用地使用權公開拍賣會中投得一幅地塊位於中國河南省新鄉市新鄉縣土地編號為2020-09號的土地使用權。
該地塊位於中國河南省新鄉市新鄉縣古固寨鎮新延路以南、政通街以西、富裕路以北,總佔地面積約44,948平方米,許可容積率介於1.0至2.0之間。該地塊分別指定為住宅用途使用年限為70年及商業用途使用年限為40年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.